The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention

European Journal of Preventive Cardiology · Published 2026-07-22 · DOI 10.1093/eurjpc/zwag313

Free full text

Authors (5)

Maya S Safarova, Laurence S. Sperling, Anurag Mehta, Harpreet S Bhatia, Fatima Rodriguez

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Safarova, M., Sperling, L., Mehta, A., et al. (2026). The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwag313

Related articles

• Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank · European Journal of Preventive Cardiology · 2026 · Same journal
• Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · European Journal of Preventive Cardiology · 2026 · Same journal
• Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · European Journal of Preventive Cardiology · 2026 · Same journal
• Cardiovascular prevention in childhood and young adults · European Journal of Preventive Cardiology · 2026 · Same journal
• Rethinking how we characterize the exercise blood pressure response in athletes · European Journal of Preventive Cardiology · 2026 · Same journal
• Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease · European Journal of Preventive Cardiology · 2026 · Same journal
• Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention · European Journal of Preventive Cardiology · 2026 · Same journal
• Safe hearts need a healthy environment: prevention beyond our clinic walls · European Journal of Preventive Cardiology · 2026 · Same journal
• Multidisciplinary cardiac rehabilitation—an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? · European Journal of Preventive Cardiology · 2026 · Same journal
• Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history · European Journal of Preventive Cardiology · 2026 · Same journal